Pfizer Won't Get To Trim BYU's Bextra-Celebrex Suit
By Roxanne Palmer ( March 13, 2012, 7:34 PM EDT) -- A Utah federal judge on Tuesday declined to rule on two claims in a contract and trade secrets suit brought against Pfizer Inc. by Brigham Young University and a professor who claims he discovered an enzyme that led to the development of the anti-inflammatory drugs Bextra and Celebrex....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.